Spinal cord stimulation therapy for gait dysfunction in progressive supranuclear palsy patients.

Olivia SamotusAndrew ParrentMandar S Jog

Published in: Journal of neurology (2020)

The results support the benefit of SCS for FOG and gait symptoms in PSP-RS and suggests early SCS intervention for dopaminergic-resistant gait should be considered.

Keyphrases

spinal cord
end stage renal disease
cerebral palsy
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
multiple sclerosis
oxidative stress
peritoneal dialysis
neuropathic pain
patient reported outcomes
patient reported